Article
Antisense Oligonucleotide STK-002 Increases OPA1 in Retina and Improves Mitochondrial Function in Autosomal Dominant Optic Atrophy Cells.
Nucleic acid therapeutics - 1 Oct 2024
Venkatesh Aditya, McKenty Taylor, Ali Syed, Sonntag Donna, Ravipaty Shobha, Cui Yanyan, Slate Deirdre, Lin Qian, Christiansen Anne, Jacobson Sarah, Kach Jacob, Lim Kian Huat, Srinivasan Vaishnavi, Zinshteyn Boris, Aznarez Isabel, Huryn Laryssa A, Li Zhiyu, Hufnagel Robert B, Liau Gene, Anderson Karen, Hoger Jeff
Abstract excerpt
Autosomal dominant optic atrophy (ADOA) is an inherited optic neuropathy most frequently associated with OPA1 mutations. Most variants result in haploinsufficiency, and patient cells express roughly half of the normal levels of OPA1 protein. OPA1 is a mitochondrial GTPase that is essential for normal mitochondrial function. We identified and characterized STK-002, an antisense oligonucleotide (ASO) designed to...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
